Skip to content

Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate …

Selecta Biosciences Announces Third Quarter 2017 Financial Results and Provides Corporate …

With these accomplishments behind us and planning for our Phase 3 … in an End-of-Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) … Head of Sanofi/Genzyme’s North American Rheumatology Business Unit.
See all stories on this topic

AROUND WEST AUGUSTINE: Meeting will offer hearing on benefits of drug court

AROUND WEST AUGUSTINE: Meeting will offer hearing on benefits of drug court … gearing up for their 4th annual Dothea H. Smith Cancer Walk to be held Saturday in support of cancer research and the American Cancer Society.
See all stories on this topic

AAC Holdings Inc. – Receive News & Ratings Daily

Shares of AAC Holdings (NYSE AAC) opened at $11.14 on Friday. … Finally, Marshall Wace North America L.P. bought a new stake in shares of AAC … AAC Holdings, Inc is a provider of inpatient and outpatient substance abuse …
See all stories on this topic

Opioid Crisis Continues to Pressure Physicians, But Patients Bear the Pain

The efforts to crack down on opioids are coming to a head. … said Joseph Ranieri, DO, an addiction medicine and pain specialist who is medical … in Salt Lake City, past president of the American Academy of Pain Medicine, and a …
See all stories on this topic

Sister: Walmart slaying suspect heard voices after drug trip

The National Institute on Drug Abuse says the long-term effects of LSD and other hallucinogenic drugs can include mood disturbances, paranoia, …
See all stories on this topic

Published inSubstance Abuse

Be First to Comment

Leave a Reply